• Pharmaceuticals discovered with AI

  • EFFICIENT DRUG DISCOVERY

    twoXAR is a pharmaceutical company that has built a development portfolio targeting more than 18 different diseases. twoXAR’s unique approach to drug discovery combines steps from the traditional multi-step approach to R&D that severely limits the pace of drug discovery. This novel method – coupled with the company’s proprietary AI-driven platform – enables twoXAR to select a disease and initiate in vivo testing in months, instead of years.

  • The Applications of AI in Drug Discovery

    twoXAR Corporate Seminar

    July 19, 2019

    LATEST EVENTS

    AAMA Global Healthcare Conference - AI: The Next Digital Frontier for Healthcare Innovation

    San Francisco, CA

    January 13, 2020

    twoXAR CEO, Andrew A. Radin, participates in a panel discussion: Every Healthcare Professionals Dream: AI in Data, Diagnosis and Patient Care.

    China Focus@San Francisco

    San Francisco, CA

    January 12, 2020

    twoXAR CEO, Andrew A. Radin, participates in a panel discussion on AI and Digital Health.

    2019 MIT Increased Productivity in the Biopharmaceutical Industry

    Boston, MA

    December 10, 2019

    twoXAR CEO, Andrew A. Radin, participates in a startup lightning talk about twoXAR and discovering pharmaceuticals with AI.